SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX

NEW YORK, Nov. 3, 2023 /PRNewswire/ -- 

Pomerantz LLP is investigating claims on behalf of investors of SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether SCYNEXIS and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On September 25, 2023, Scynexis announced a recall of its anti-fungal therapy ibrexafungerp and placing a temporary hold on its clinical studies due to the risk of a potential contaminant.  The Company stated that the decision to recall follows an investigation that found the production of a contaminant called a beta-lactam drug substance during ibrexafungerp's manufacturing process.  The non-antibacterial compound can lead to hypersensitivity or allergic reactions in some individuals. 

On this news, Scynexis's stock price fell $1.38 per share, or 41.69%, over the following two trading sessions, to close at $1.38 per share on September 26, 2023.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980

SOURCE Pomerantz LLP